These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 12645941

  • 1. Mice transgenic for intracellular interleukin-1 receptor antagonist type 1 are protected from collagen-induced arthritis.
    Palmer G, Talabot-Ayer D, Szalay-Quinodoz I, Maret M, Arend WP, Gabay C.
    Eur J Immunol; 2003 Feb; 33(2):434-40. PubMed ID: 12645941
    [Abstract] [Full Text] [Related]

  • 2. Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis.
    Gabay C, Marinova-Mutafchieva L, Williams RO, Gigley JP, Butler DM, Feldmann M, Arend WP.
    Arthritis Rheum; 2001 Feb; 44(2):451-62. PubMed ID: 11229477
    [Abstract] [Full Text] [Related]

  • 3. Action of intracellular IL-1Ra (Type 1) is independent of the IL-1 intracellular signalling pathway.
    Evans I, Dower SK, Francis SE, Crossman DC, Wilson HL.
    Cytokine; 2006 Mar 07; 33(5):274-80. PubMed ID: 16564702
    [Abstract] [Full Text] [Related]

  • 4. Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice.
    Lamacchia C, Rodriguez E, Palmer G, Vigne S, Martin P, Talabot-Ayer D, Seemayer CA, Gabay C.
    Ann Rheum Dis; 2012 Feb 07; 71(2):281-7. PubMed ID: 22072017
    [Abstract] [Full Text] [Related]

  • 5. Pre-interleukin-1alpha expression reduces cell growth and increases interleukin-6 production in SaOS-2 osteosarcoma cells: Differential inhibitory effect of interleukin-1 receptor antagonist (icIL-1Ra1).
    Palmer G, Trolliet S, Talabot-Ayer D, Mézin F, Magne D, Gabay C.
    Cytokine; 2005 Jul 21; 31(2):153-60. PubMed ID: 15923123
    [Abstract] [Full Text] [Related]

  • 6. Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo.
    Gabay C, Porter B, Fantuzzi G, Arend WP.
    J Immunol; 1997 Dec 15; 159(12):5905-13. PubMed ID: 9550387
    [Abstract] [Full Text] [Related]

  • 7. Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1α.
    Martin P, Palmer G, Rodriguez E, Palomo J, Lemeille S, Goldstein J, Gabay C.
    J Immunol; 2020 Feb 15; 204(4):967-979. PubMed ID: 31932497
    [Abstract] [Full Text] [Related]

  • 8. Intracellular IL-1 receptor antagonist type 1 inhibits IL-1-induced cytokine production in keratinocytes through binding to the third component of the COP9 signalosome.
    Banda NK, Guthridge C, Sheppard D, Cairns KS, Muggli M, Bech-Otschir D, Dubiel W, Arend WP.
    J Immunol; 2005 Mar 15; 174(6):3608-16. PubMed ID: 15749898
    [Abstract] [Full Text] [Related]

  • 9. Intracellular IL-1Ra type 1 inhibits IL-1-induced IL-6 and IL-8 production in Caco-2 intestinal epithelial cells through inhibition of p38 mitogen-activated protein kinase and NF-kappaB pathways.
    Garat C, Arend WP.
    Cytokine; 2003 Jul 15; 23(1-2):31-40. PubMed ID: 12901852
    [Abstract] [Full Text] [Related]

  • 10. Production of interleukin-1 receptor antagonist by human articular chondrocytes.
    Palmer G, Guerne PA, Mezin F, Maret M, Guicheux J, Goldring MB, Gabay C.
    Arthritis Res; 2002 Jul 15; 4(3):226-31. PubMed ID: 12010575
    [Abstract] [Full Text] [Related]

  • 11. Production of intracellular IL-1alpha, IL-1beta, and IL-1Ra isoforms by activated human dermal and synovial fibroblasts: phenotypic differences between human dermal and synovial fibroblasts.
    Maret M, Chicheportiche R, Dayer JM, Gabay C.
    Cytokine; 2004 Mar 07; 25(5):193-203. PubMed ID: 15036245
    [Abstract] [Full Text] [Related]

  • 12. Characterization of a low molecular weight isoform of IL-1 receptor antagonist.
    Malyak M, Guthridge JM, Hance KR, Dower SK, Freed JH, Arend WP.
    J Immunol; 1998 Aug 15; 161(4):1997-2003. PubMed ID: 9712072
    [Abstract] [Full Text] [Related]

  • 13. Intracellular interleukin-1 receptor antagonist type 1 antagonizes the stimulatory effect of interleukin-1 alpha precursor on cell motility.
    Merhi-Soussi F, Berti M, Wehrle-Haller B, Gabay C.
    Cytokine; 2005 Nov 03; 32(3-4):163-70. PubMed ID: 16246569
    [Abstract] [Full Text] [Related]

  • 14. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB.
    Arthritis Res; 1999 Nov 03; 1(1):81-91. PubMed ID: 11056663
    [Abstract] [Full Text] [Related]

  • 15. Comparison of two promoters controlling expression of secreted or intracellular IL-1 receptor antagonist.
    Butcher C, Steinkasserer A, Tejura S, Lennard AC.
    J Immunol; 1994 Jul 15; 153(2):701-11. PubMed ID: 8021506
    [Abstract] [Full Text] [Related]

  • 16. Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein.
    Gabay C, Smith MF, Eidlen D, Arend WP.
    J Clin Invest; 1997 Jun 15; 99(12):2930-40. PubMed ID: 9185517
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of daily compared to intermittent administration of IL-1Ra for protection against bone and cartilage destruction in collagen-challenged mice.
    Inoue K, Masuko-Hongo K, Okamoto M, Nishioka K.
    Clin Exp Rheumatol; 2003 Jun 15; 21(1):33-9. PubMed ID: 12673887
    [Abstract] [Full Text] [Related]

  • 18. Production of IL-1 receptor antagonist by hepatocytes is regulated as an acute-phase protein in vivo.
    Gabay C, Gigley J, Sipe J, Arend WP, Fantuzzi G.
    Eur J Immunol; 2001 Feb 15; 31(2):490-9. PubMed ID: 11180114
    [Abstract] [Full Text] [Related]

  • 19. The differential production of three forms of IL-1 receptor antagonist by human neutrophils and monocytes.
    Malyak M, Smith MF, Abel AA, Hance KR, Arend WP.
    J Immunol; 1998 Aug 15; 161(4):2004-10. PubMed ID: 9712073
    [Abstract] [Full Text] [Related]

  • 20. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
    Smeets RL, Joosten LA, Arntz OJ, Bennink MB, Takahashi N, Carlsen H, Martin MU, van den Berg WB, van de Loo FA.
    Arthritis Rheum; 2005 Jul 15; 52(7):2202-11. PubMed ID: 15986350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.